Paula Proszek - Concepedia

Author

Paula Proszek

Also Known As

D B Begum, Ghosal, Abhisek, P Proszek, P. Proszek, Paula Proszek, Paula Z. Proszek, Paula Zuzanna Proszek, Proszek, Paula

300

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research Royal Marsden NHS Foundation Trust University College London Newcastle University Royal Marsden Hospital

About

Paula Proszek is an author at Institute of Cancer Research specializing in cancer research, radiation oncology, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	288
2	Pathology	2	2	288
3	Health Sciences	1	1	251
4	Cell Biology	1	1	37
5	Radiation Medicine	1	1	37

Paula Proszek

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, Journal of Clinical Oncology	2015	557
Signatures of copy number alterations in human cancer Christopher D. Steele, Ammal Abbasi, S. M. Ashiqul Islam, Nature	2022	472
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma Brian A. Walker, Christopher P. Wardell, Alex Murison, Nature Communications	2015	309
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes Matthew Clarke, Alan Mackay, Britta Ismer, Cancer Discovery	2020	264
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer Neha Chopra, Holly Tovey, Alex Pearson, Nature Communications	2020	252
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology Ira W. Deveson, Binsheng Gong, Kevin Lai, Nature Biotechnology OncologyCancer DetectionTumor HeterogeneityMedicinePathology	2021	251
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial Khurum Khan, David Cunningham, Benjamin Werner, Cancer Discovery	2018	233
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer Nicholas C. Turner, Claire Swift, Ben Jenkins, Annals of Oncology	2022	173
Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance Alex Pearson, Paula Proszek, Javier Pascual, Clinical Cancer Research	2019	125
The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma Charlotte Pawlyn, Martin Kaiser, Christoph Heuck, Clinical Cancer Research	2016	94

Page 1